• Therapeutic Category
  • Pharmaceutical Form : Syrup
  • Composition : Dextromethorphane HBr 10 mg + Guaifenesine 100 mg /5ml
  • Active Substance : Dextromethorphane HBr+ Guaifenesine


 NEW Pectomed Adults combines the expectorant, guaifenesin, and the cough suppressant, dextromethorphan hydrobromide.

Dextromethorphan is a synthetic nonopioid cough suppressant, the dextro isomer of the codeine analogue of levorphanol. Dextromethorphan acts centrally to elevate the threshold for coughing but does not have addictive, analgesic or sedative actions and does not produce respiratory depression with usual doses.


NEW Pectomed Adults Temporarily relieves cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants. Calms the cough control center and relieves coughing.


Hypersensitivity to any of the ingredients.

The use of dextromethorphan-containing products are contraindicated in patients receiving monoamine oxidase inhibitors (MAOIs)


Teratogenic Effects–Pregnancy Category C: these products should not be used in pregnant patients unless, in the judgment of the physician, the potential benefits outweigh possible hazards.

Nonteratogenic Effects: Dependence has been reported in newborns whose mothers took opiates regularly during pregnancy. Withdrawal signs include irritability, excessive crying, tremors, hyperreflexia, fever, vomiting, and diarrhea. Signs usually appear during the first few days of life.

Nursing Mothers: caution should be exercised when these products are administered to a nursing woman and a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Drug Interactions:

Pectomed Adults Serious toxicity may result if dextromethorphan is coadministered with monoamine oxidase inhibitors (MAOIs). The use of dextromethorphan hydrobromide may result in additive CNS depressant effects when coadministered with alcohol, antihistamines, psychotropics or other drugs that produce CNS depression.

Adverse Reactions:

Guaifenesin is well tolerated and has a wide margin of safety. Side effects have been generally mild and infrequent. Nausea and vomiting are the side effects that occur most commonly. Dizziness, headache, and rash (including urticaria) have been reported rarely.

Dextromethorphan [NEW Pectomed Adults]: Rare drowsiness or mild gastrointestinal disturbances are the only side effects associated with dextromethorphan in clinical use.

Over Dosage:

Over dosage with dextromethorphan may produce excitement and mental confusion. Very high doses may produce respiratory depression. One case of toxic psychosis (hyperactivity, marked visual and auditory hallucinations) after ingestion of a single 300 mg dose of dextromethorphan has been reported.

Dosage and Administration:

NEW Pectomed Adults

Adults and children 12 years of age and older: 2 teaspoonfuls (10 mL) every four hours not to exceed 12 teaspoonfuls (60 mL) in 24 hours.

Storage Condition: Store at controlled room temperature 20°-25°C.

How Supplied: NEW Pectomed Adults 100 ml class bottle.